PROCEPT BioRobotics Revenue and Competitors

Location

#1415

Growjo Ranking

Estimated Revenue & Valuation

  • PROCEPT BioRobotics's estimated annual revenue is currently $235.8M per year.(i)
  • PROCEPT BioRobotics received $118.0M in venture funding in February 2018.
  • PROCEPT BioRobotics's estimated revenue per employee is $351,400
  • PROCEPT BioRobotics's total funding is $349M.

Employee Data

  • PROCEPT BioRobotics has 671 Employees.(i)
  • PROCEPT BioRobotics grew their employee count by 39% last year.

PROCEPT BioRobotics's People

NameTitleEmail/Phone
1
President& CEOReveal Email/Phone
2
Sr. Director Product ManagementReveal Email/Phone
3
Director Global MarketingReveal Email/Phone
4
Aquablation Clinical ManagerReveal Email/Phone
5
Senior Manager, Systems, Controls, and RoboticsReveal Email/Phone
6
Regional Sales Manager - Central USReveal Email/Phone
7
Aquablation Sales RepresentativeReveal Email/Phone
8
Robotic Sales North EastReveal Email/Phone
9
Engineering ManagerReveal Email/Phone
10
Senior Aquablation Sales RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is PROCEPT BioRobotics?

Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), the company's first product, the AQUABEAM System delivering Aquablation therapy, is the world's first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat BPH. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

$349M

Total Funding

671

Number of Employees

$235.8M

Revenue (est)

39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PROCEPT BioRobotics News

2022-04-06 - PROCEPT BioRobotics Corp. Announces Investor Event at ...

PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans. PROCEPT BioRobotics (GLOBE NEWSWIRE)...

2022-04-06 - PROCEPT BioRobotics Corp. to Report First Quarter 2022 ...

PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare...

2022-04-06 - PROCEPT BioRobotics Corp. Announces Investor Event at ...

REDWOOD CITY, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused...

2021-11-04 - PROCEPT BioRobotics Corp. Reports Third Quarter 2021 Financial Results and Provides 2021 Revenue Guidance

REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the quarter ended September 30, 2021. Re ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$527.4M17947%N/A
#2
$4414.8M21748N/AN/A

PROCEPT BioRobotics Funding

DateAmountRoundLead InvestorsReference
2015-07-08$42.0MUndisclosedNovo A/SArticle
2015-07-21$7.7MUndisclosedArticle
2018-02-22$118.0MUndisclosedViking Global Investors LPArticle